Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1203797

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1203797

Proteinase K Market Research Report by Therapeutic Area (Autoimmune Diseases, Cardiology, and Diabetes), Form, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, High Inflation - Global Forecast 2023-2030

PUBLISHED:
PAGES: 251 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & Online Access - 1 Year (Single User License)
USD 4749
PDF, Excel & Online Access - 1 Year (Up to 5 User License)
USD 5749
PDF, Excel & Online Access - 1 Year (Site License)
USD 6749
PDF, Excel & Online Access - 1 Year (Enterprise User License)
USD 8749

Add to Cart

The Global Proteinase K Market size was estimated at USD 64.80 million in 2022 and expected to reach USD 70.28 million in 2023, projecting growth at a CAGR of 8.58% to reach USD 125.26 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Proteinase K Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people's lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Proteinase K Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Proteinase K Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Proteinase K Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the Global Proteinase K Market in order to forecast the revenues and analyze the trends in each of the following sub-markets.

Based on Therapeutic Area, the market is studied across Autoimmune Diseases, Cardiology, Diabetes, Infectious Diseases, Nephrology, Neurology, and Oncology.

Based on Form, the market is studied across Liquid and Powder.

Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Proteinase K Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Proteinase K Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Proteinase K Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Proteinase K Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor's strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Proteinase K Market, including Advanced Enzymes Technologies Ltd., Amano Enzyme Inc., American Laboratories, Biocatalysts Ltd., BIORON GmbH, Codexis, Inc., Dyadic International, Inc., F. Hoffmann-La Roche Ltd., Gproan Biotechnologies, Merck KGaA, Norgen Biotek Corporation, Promega Corporation, Qiagen N.V., Thermo Fisher Scientific, Inc., and Worthington Biochemical Corporation.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Proteinase K Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Proteinase K Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Proteinase K Market?

4. What is the competitive strategic window for opportunities in the Global Proteinase K Market?

5. What are the technology trends and regulatory frameworks in the Global Proteinase K Market?

6. What is the market share of the leading vendors in the Global Proteinase K Market?

7. What modes and strategic moves are considered suitable for entering the Global Proteinase K Market?

Product Code: MRR-4F4C36263B29

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for nucleic acid purification
      • 5.1.1.2. Improved cloning efficiency and tissue digestion
      • 5.1.1.3. Demand for proteinase K in POC diagnostics applications
    • 5.1.2. Restraints
      • 5.1.2.1. Presence of substitute
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing R&D in the field like 3D printing and tissue reengineering
      • 5.1.3.2. Government initiatives taken in pharmaceutical industry
    • 5.1.4. Challenges
      • 5.1.4.1. Introduction of new sophisticated technologies for DNA purification
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Cumulative Impact of Russia-Ukraine Conflict
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Threat of Substitutes
    • 5.5.4. Threat of Substitutes
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework
  • 5.8. Client Customization

6. Proteinase K Market, by Therapeutic Area

  • 6.1. Introduction
  • 6.2. Autoimmune Diseases
  • 6.3. Cardiology
  • 6.4. Diabetes
  • 6.5. Infectious Diseases
  • 6.6. Nephrology
  • 6.7. Neurology
  • 6.8. Oncology

7. Proteinase K Market, by Form

  • 7.1. Introduction
  • 7.2. Liquid
  • 7.3. Powder

8. Americas Proteinase K Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Proteinase K Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Proteinase K Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis, By Key Player
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Product Portfolio Analysis, By Key Player
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Advanced Enzymes Technologies Ltd.
  • 12.2. Amano Enzyme Inc.
  • 12.3. American Laboratories
  • 12.4. Biocatalysts Ltd.
  • 12.5. BIORON GmbH
  • 12.6. Codexis, Inc.
  • 12.7. Dyadic International, Inc.
  • 12.8. F. Hoffmann-La Roche Ltd.
  • 12.9. Gproan Biotechnologies
  • 12.10. Merck KGaA
  • 12.11. Norgen Biotek Corporation
  • 12.12. Promega Corporation
  • 12.13. Qiagen N.V.
  • 12.14. Thermo Fisher Scientific, Inc.
  • 12.15. Worthington Biochemical Corporation

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
Product Code: MRR-4F4C36263B29

LIST OF FIGURES

  • FIGURE 1. GLOBAL PROTEINASE K MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL PROTEINASE K MARKET SIZE, 2022 VS 2030
  • FIGURE 3. GLOBAL PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PROTEINASE K MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. GLOBAL PROTEINASE K MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PROTEINASE K MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
  • FIGURE 7. GLOBAL PROTEINASE K MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 8. GLOBAL PROTEINASE K MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PROTEINASE K MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 10. GLOBAL PROTEINASE K MARKET DYNAMICS
  • FIGURE 11. GLOBAL PROTEINASE K MARKET PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 12. GLOBAL PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2030 (%)
  • FIGURE 13. GLOBAL PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PROTEINASE K MARKET COMPETITIVE STRATEGIC WINDOW, BY THERAPEUTIC AREA, 2030
  • FIGURE 15. GLOBAL PROTEINASE K MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • FIGURE 16. GLOBAL PROTEINASE K MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • FIGURE 17. GLOBAL PROTEINASE K MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
  • FIGURE 18. GLOBAL PROTEINASE K MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • FIGURE 19. GLOBAL PROTEINASE K MARKET SIZE, BY NEPHROLOGY, 2018-2030 (USD MILLION)
  • FIGURE 20. GLOBAL PROTEINASE K MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • FIGURE 21. GLOBAL PROTEINASE K MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • FIGURE 22. GLOBAL PROTEINASE K MARKET SIZE, BY FORM, 2022 VS 2030 (%)
  • FIGURE 23. GLOBAL PROTEINASE K MARKET SIZE, BY FORM, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 24. GLOBAL PROTEINASE K MARKET COMPETITIVE STRATEGIC WINDOW, BY FORM, 2030
  • FIGURE 25. GLOBAL PROTEINASE K MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
  • FIGURE 26. GLOBAL PROTEINASE K MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
  • FIGURE 27. AMERICAS PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 28. AMERICAS PROTEINASE K MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 29. AMERICAS PROTEINASE K MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 30. AMERICAS PROTEINASE K MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 31. ARGENTINA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 32. BRAZIL PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 33. CANADA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 34. MEXICO PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 35. UNITED STATES PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 36. UNITED STATES PROTEINASE K MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 37. UNITED STATES PROTEINASE K MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 38. UNITED STATES PROTEINASE K MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
  • FIGURE 39. ASIA-PACIFIC PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 40. ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 41. ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 42. ASIA-PACIFIC PROTEINASE K MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 43. AUSTRALIA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 44. CHINA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 45. INDIA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 46. INDONESIA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 47. JAPAN PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 48. MALAYSIA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 49. PHILIPPINES PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 50. SINGAPORE PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 51. SOUTH KOREA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 52. TAIWAN PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 53. THAILAND PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 54. VIETNAM PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 55. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 56. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 57. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 58. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
  • FIGURE 59. DENMARK PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 60. EGYPT PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 61. FINLAND PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 62. FRANCE PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 63. GERMANY PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 64. ISRAEL PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 65. ITALY PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 66. NETHERLANDS PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 67. NIGERIA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 68. NORWAY PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 69. POLAND PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 70. QATAR PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 71. RUSSIA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 72. SAUDI ARABIA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 73. SOUTH AFRICA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 74. SPAIN PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 75. SWEDEN PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 76. SWITZERLAND PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 77. TURKEY PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 78. UNITED ARAB EMIRATES PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 79. UNITED KINGDOM PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 80. GLOBAL PROTEINASE K MARKET: FPNV POSITIONING MATRIX, 2022
  • FIGURE 81. GLOBAL PROTEINASE K MARKET SHARE, BY KEY PLAYER, 2022
  • FIGURE 82. GLOBAL PROTEINASE K MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

LIST OF TABLES

  • TABLE 1. GLOBAL PROTEINASE K MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. GLOBAL PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PROTEINASE K MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PROTEINASE K MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLOBAL PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 7. GLOBAL PROTEINASE K MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PROTEINASE K MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PROTEINASE K MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PROTEINASE K MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PROTEINASE K MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PROTEINASE K MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PROTEINASE K MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PROTEINASE K MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PROTEINASE K MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PROTEINASE K MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PROTEINASE K MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PROTEINASE K MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PROTEINASE K MARKET SIZE, BY NEPHROLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PROTEINASE K MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PROTEINASE K MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PROTEINASE K MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PROTEINASE K MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PROTEINASE K MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PROTEINASE K MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PROTEINASE K MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PROTEINASE K MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PROTEINASE K MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PROTEINASE K MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PROTEINASE K MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PROTEINASE K MARKET SIZE, BY POWDER, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PROTEINASE K MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PROTEINASE K MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS PROTEINASE K MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES PROTEINASE K MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 89. THAILAND PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 92. VIETNAM PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 93. VIETNAM PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 99. DENMARK PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 100. DENMARK PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 101. DENMARK PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 102. EGYPT PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 103. EGYPT PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 104. EGYPT PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 105. FINLAND PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 106. FINLAND PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 107. FINLAND PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 108. FRANCE PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 109. FRANCE PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 110. FRANCE PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 111. GERMANY PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 112. GERMANY PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 113. GERMANY PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 114. ISRAEL PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 115. ISRAEL PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 116. ISRAEL PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 117. ITALY PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 118. ITALY PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 119. ITALY PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 120. NETHERLANDS PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 121. NETHERLANDS PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 122. NETHERLANDS PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 123. NIGERIA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 124. NIGERIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 125. NIGERIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 126. NORWAY PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 127. NORWAY PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 128. NORWAY PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 129. POLAND PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 130. POLAND PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 131. POLAND PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 132. QATAR PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 133. QATAR PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 134. QATAR PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 135. RUSSIA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 136. RUSSIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 137. RUSSIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 138. SAUDI ARABIA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 139. SAUDI ARABIA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 140. SAUDI ARABIA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH AFRICA PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH AFRICA PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH AFRICA PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 144. SPAIN PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 145. SPAIN PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 146. SPAIN PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 147. SWEDEN PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 148. SWEDEN PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 149. SWEDEN PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 150. SWITZERLAND PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 151. SWITZERLAND PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 152. SWITZERLAND PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 153. TURKEY PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 154. TURKEY PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 155. TURKEY PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 156. UNITED ARAB EMIRATES PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 157. UNITED ARAB EMIRATES PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 158. UNITED ARAB EMIRATES PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 159. UNITED KINGDOM PROTEINASE K MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 160. UNITED KINGDOM PROTEINASE K MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 161. UNITED KINGDOM PROTEINASE K MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 162. GLOBAL PROTEINASE K MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
  • TABLE 163. GLOBAL PROTEINASE K MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
  • TABLE 164. GLOBAL PROTEINASE K MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
  • TABLE 165. GLOBAL PROTEINASE K MARKET RANKING, BY KEY PLAYER, 2022
  • TABLE 166. GLOBAL PROTEINASE K MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 167. GLOBAL PROTEINASE K MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
  • TABLE 168. GLOBAL PROTEINASE K MARKET MERGER & ACQUISITION
  • TABLE 169. GLOBAL PROTEINASE K MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 170. GLOBAL PROTEINASE K MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 171. GLOBAL PROTEINASE K MARKET INVESTMENT & FUNDING
  • TABLE 172. GLOBAL PROTEINASE K MARKET AWARD, RECOGNITION, & EXPANSION
  • TABLE 173. GLOBAL PROTEINASE K MARKET: LICENSE & PRICING
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!